FDA approves lab to begin stem cell trial for #COVID19 
Creative Medical ( $CELZ), is also a biotechnology company focused on Stem-Cell-Therapy

#stocks #covid @VP #CNBC
$ROTH $ATNM $AIM $APTO $BIOC $INO $BRTX $NOVN $OCGN $T $F $C $SBFM $TSOI $TGODF $BLEVF
https://t.co/c3ulWGNyFt